This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Chong Kun Dang Pharmaceutical Corporation, Inje University Industry-Academic Cooperation Foundation. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 52 
1 out of 69 Years Active: 2016-2022
Title: NiNa Ha: Innovator in Pharmaceutical Compounds
Introduction
NiNa Ha is a prominent inventor based in Yongin, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents, her work focuses on innovative solutions for various medical conditions.
Latest Patents
NiNa Ha's latest patents include groundbreaking inventions such as "Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same." This invention relates to novel heterocyclicalkyl derivatives that exhibit histone deacetylase (HDAC) inhibitory activity. These compounds are designed for the preparation of medicaments and pharmaceutical compositions aimed at treating diseases mediated by HDAC, including cell proliferative diseases, inflammatory diseases, and neurodegenerative diseases.
Another significant patent is for "N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug." This invention focuses on novel N-acylhydrazone derivatives that possess selective T cell inhibitory activity and anti-lymphoid malignancy properties. The patent outlines methods for preparing these derivatives and their use in pharmaceutical compositions for treating various malignancies.
Career Highlights
Throughout her career, NiNa Ha has worked with notable organizations, including Chong Kun Dang Pharmaceutical Corporation and Inje University Industry-Academic Cooperation Foundation. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
NiNa Ha has collaborated with esteemed colleagues, including JaeWon Lee and JaeKwang Lee. These partnerships have fostered a collaborative environment that enhances the research and development of her innovative compounds.
Conclusion
NiNa Ha is a trailblazer in the pharmaceutical industry, with a focus on developing novel compounds that address critical health issues. Her contributions through her patents reflect her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile